Gene · 779
Papers2,128
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,128
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Probing ion binding in the selectivity filter of the Cav1.1 channel with molecular dynamics. | Biophys J | 2023 | 36587239 | PubTator, text mining | PubMed |
| Modulation of L-type calcium channels in Alzheimer's disease: A potential therapeutic target. | Comput Struct Biotechnol J | 2023 | 36514335 | PubTator, text mining | PubMed |
| Potential binding modes of the gut bacterial metabolite, 5-hydroxyindole, to the intestinal L-type calcium channels and its impact on the microbiota in rats. | Gut Microbes | 2023 | 36511640 | PubTator, text mining | PubMed |
| Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services. | Clin Transl Sci | 2023 | 36510710 | PubTator, text mining | PubMed |
| Huntingtin regulates calcium fluxes in skeletal muscle. | J Gen Physiol | 2023 | 36409218 | PubTator, text mining | PubMed |
| RYR-1-Related Diseases International Research Workshop: From Mechanisms to Treatments Pittsburgh, PA, U.S.A., 21-22 July 2022. | J Neuromuscul Dis | 2023 | 36404556 | PubTator, text mining | PubMed |
| Metabolic, fibrotic and splicing pathways are all altered in Emery-Dreifuss muscular dystrophy spectrum patients to differing degrees. | Hum Mol Genet | 2023 | 36282542 | PubTator, text mining | PubMed |
| Dynamics and variability of transcriptomic dysregulation in congenital myotonic dystrophy during pediatric development. | Hum Mol Genet | 2023 | 36222125 | PubTator, text mining | PubMed |
| Germline de novo variant F747S extends the phenotypic spectrum of CACNA1D Ca2+ channelopathies. | Hum Mol Genet | 2023 | 36208199 | PubTator, text mining | PubMed |
| Endoplasmic Reticulum-Plasma Membrane Junctions as Sites of Depolarization-Induced Ca2+ Signaling in Excitable Cells. | Annu Rev Physiol | 2023 | 36202100 | PubTator, text mining | PubMed |
| Oral Dantrolene for Myopathic Symptoms in Malignant Hyperthermia-Susceptible Patients: A 25-Year Retrospective Cohort Study of Adverse Effects and Tolerability. | Anesth Analg | 2023 | 36201369 | PubTator, text mining | PubMed |
| Placental ion channels: potential target of chemical exposure. | Biol Reprod | 2023 | 36173899 | PubTator, text mining | PubMed |
| Pharmacogenetic profiling via genome sequencing in children with medical complexity. | Pediatr Res | 2023 | 36167815 | PubTator, text mining | PubMed |
| Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders. | Neuropsychopharmacology | 2023 | 36114287 | PubTator, text mining | PubMed |
| Impairment of kidney function and kidney cancer: A bidirectional Mendelian randomization study. | Cancer Med | 2023 | 36069056 | PubTator, text mining | PubMed |
| Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects. | Cardiovasc Res | 2023 | 35895876 | PubTator, text mining | PubMed |
| Predictive factors of the contracture test for diagnosing malignant hyperthermia in a Brazilian population sample: a retrospective observational study. | Braz J Anesthesiol | 2023 | 35835312 | PubTator, text mining | PubMed |
| A spectrum of clinical severity of recessive titinopathies in prenatal. | Front Genet | 2022 | 36761691 | PubTator, text mining | PubMed |
| Neuromuscular symptoms in patients with RYR1-related malignant hyperthermia and rhabdomyolysis. | Brain Commun | 2022 | 36751502 | PubTator, text mining | PubMed |
| Case report: SCN4A p.R1135H gene variant in combination with thyrotoxicosis causing hypokalemic periodic paralysis. | Front Neurol | 2022 | 36733446 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/779/papers?page=14